Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The Waismann Method® Now Provides Medically Supervised Alcohol Detox Treatment

The Waismann Method® is proud to announce the opening of their medically supervised alcohol detoxification program. Patients who enter the detoxification program are followed at a JCAHO-accredited hospital supervised by Waismann Method® medical director, Michael H. Lowenstein, MD.


News provided by

Waismann Method

Sep 18, 2018, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Medically Assisted Alcohol and Opioid Detox Treatment
Medically Assisted Alcohol and Opioid Detox Treatment

BEVERLY HILLS, Calif., Sept. 18, 2018 /PRNewswire-PRWeb/ -- The Waismann Method® Now Provides Medically Supervised Alcohol Detox

The Waismann Method® is proud to announce the opening of their medically supervised alcohol detoxification program. Alcohol-dependent patients can now enter the Waismann Method® to safely detox from alcohol without co-morbid opioid addiction.

We strongly believe that most acute alcohol detox should be managed in the hospital by experienced physicians so that appropriate medical resources are immediately available

Post this

The The Waismann Method Waismann Method® has become Southern California's premier medically supervised opioid detox program, delivering care for thousands of patients over the last couple of decades. While the addiction specialists at the Waismann Method® are widely known for their expertise in opioid detox, many of their patients also have comorbid alcohol abuse problems. Many of the same detoxification principles that are used to treat people dependent on opioids can be applied to people dependent on alcohol. "[Alcohol detox] was a natural extension of our work with opioid-dependent patients," says Clare Waismann, Founder of the Waismann Method®.

Alcohol-dependent individuals often need substantial doses of benzodiazepines in the early stages of withdrawal, for example, to prevent alcohol-withdrawal seizures and delirium tremens (better known as DTs). Delirium tremens typically begins 48 to 96 hours after the patient's last drink and lasts for up to five days. The hallmarks of DTs are disorientation, rapid heart rate, high blood pressure, elevated body temperature, extreme agitation, sweating, and hallucinations. A separate condition called alcoholic hallucinosis is separate from the hallucinations that occur during delirium tremens and can develop within 12 to 24 hours of the patient's last drink.

"We strongly believe that most acute alcohol detox should be managed in the hospital by experienced physicians so that appropriate medical resources are immediately available," says Waismann.

Patients who enter the detoxification program are followed at a JCAHO-accredited hospital supervised by Waismann Method® medical director, Michael H. Lowenstein, MD. Dr. Lowenstein is a Diplomate of the American Board of Pain Medicine and has over 20 years of experience in Addiction Medicine. "The providers in our program have the knowledge and experience that comes from years of treating people with both opioid and alcohol addiction," states Dr. Lowenstein, "patients do not need to have problems with opioids to tap into our expertise on alcohol dependence treatment."

Patients who enter the Waismann Method® program are first admitted to an accredited, full-service hospital so they can be closely followed during the riskier stages of alcohol detox. Once patients successfully detox from alcohol, they transition to the Domus Retreat aftercare program. This program offers one-on-one psychotherapy sessions, individualized treatment programs, recovery therapies and round the clock client care. The Domus Retreat offers the amenities of a luxury resort to ease the transition from alcohol addiction to sustained health. "Patients first go through detox to halt the effects of alcohol abuse on the body, and then spend time at the retreat to rebuild their physical, mental, and emotional strength," says Waismann.

About the Waismann Method
Waismann Method® offers medically assisted detoxification treatment in a Full-Service JCAHO Accredited Hospital in Southern California. Medically directed by Dr. Michael H. Lowenstein, the Waismann Method® is the premier medical opiate detoxification and rapid detox center in the US. Dr. Lowenstein is recognized nationally and internationally as an expert in opioid dependence and rapid detox treatment. He leads a team of healthcare professionals that consistently provide humane, dignified, and effective drug treatment. This commitment to providing excellent care for patients struggling with opioid addiction and superior results is as strong today as it was 20 years ago when we started.

SOURCE Waismann Method

Related Links

opiates.com

Modal title

Private Accredited Full Service Hospital
Private Accredited Full Service Hospital
Private Accredited Full Service Hospital

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.